Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pak Fah Yeow InternationalHKSE:00239 76 PS Ratio is 3.55 as of Aug. 19, 2026, which is 9% below its 10-year median of 3.89. GuruFocus rates HKSE:00239 with a GF Score™ of 76/100 and a GF Value™ of HK$2.18 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 950 Drug Manufacturers companies, Pak Fah Yeow International ranks worse than 63.58% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Pak Fah Yeow International's share price is HK$2.44.
Pak Fah Yeow International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.69. Hence, Pak Fah Yeow International's PS Ratio for today is 3.55.
Warning Sign:
Pak Fah Yeow International Ltd stock PS Ratio (=3.55) is close to 3-year high of 3.81.
The historical rank and industry rank for Pak Fah Yeow International's PS Ratio or its related term are showing as below:
HKSE:00239'
s PS Ratio Range Over the Past 10 Years
Min: 2.08 Med: 3.89 Max: 6.78
Current: 3.55
During the past 13 years, Pak Fah Yeow International's highest PS Ratio was 6.78. The lowest was 2.08. And the median was 3.89.
HKSE:00239's PS Ratio is ranked worse than 63.58% of 950
companies
in the Drug Manufacturers industry
Industry Median: 2.33
vs HKSE:00239: 3.55
Pak Fah Yeow International Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Pak Fah Yeow International was -9.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 13.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 17.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.80% per year.
During the past 13 years, Pak Fah Yeow International's highest 3-Year average Revenue per Share Growth Rate was 33.30% per year. The lowest was -15.10% per year. And the median was 3.90% per year.
Pak Fah Yeow International (HKSE:00239) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Pak Fah Yeow International PS Ratio Related Terms
Pak Fah Yeow International PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pak Fah Yeow International PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's PS Ratio distribution charts can be found below:
* The bar in red indicates where Pak Fah Yeow International's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Pak Fah Yeow International's Share Price of today is HK$2.44.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pak Fah Yeow International's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.69.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Pak Fah Yeow International (HKSE:00239) has a PS Ratio of 3.55 as of Aug. 19, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Pak Fah Yeow International and its competitors. This is near median its historical median of 3.89. Over the past decade, Pak Fah Yeow International's PS Ratio has ranged from 2.08 to 6.78. According to the industry distribution chart, Pak Fah Yeow International ranks #604 out of 950 companies in the Drug Manufacturers industry, placing it in the top 63.6%.
Is Pak Fah Yeow International's PS Ratio too high?
Pak Fah Yeow International's current PS Ratio of 3.55 is near median its 10-year median of 3.89. Over the past 10 years, this metric has ranged from a low of 2.08 to a high of 6.78. The Drug Manufacturers industry median PS Ratio is 2.33. Pak Fah Yeow International's value of 3.55 is 52.4% above this industry median. Based on the distribution chart, Pak Fah Yeow International ranks #604 out of 950 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Pak Fah Yeow International has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pak Fah Yeow International's PS Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pak Fah Yeow International ranks #604 out of 950 companies for PS Ratio. This places Pak Fah Yeow International in the lower half of its industry. The industry median PS Ratio is 2.33. Pak Fah Yeow International's value of 3.55 is 52.4% above this benchmark. Historically, Pak Fah Yeow International's own PS Ratio has ranged from 2.08 to 6.78 over the past decade. While the company's 10-year median is 3.89 vs. the industry median of 2.33, Pak Fah Yeow International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.33, based on 950 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pak Fah Yeow International's current PS Ratio of 3.55 is 52.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Pak Fah Yeow International and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pak Fah Yeow International's current PS Ratio is 3.55, which is near median its own 10-year median of 3.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pak Fah Yeow International stock overvalued right now?
Based on GuruFocus' analysis, Pak Fah Yeow International (HKSE:00239) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$2.18, compared to a current price of HK$2.44 — trading 11.9% above its estimated fair value. The current PS Ratio is 3.55, which is near median its 10-year median of 3.89 and 52.4% above the Drug Manufacturers industry median of 2.33. Pak Fah Yeow International's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Pak Fah Yeow International (HKSE:00239), the current PS Ratio is 3.55 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pak Fah Yeow International (HKSE:00239) Overvalued in 2026?
Based on GuruFocus' analysis, Pak Fah Yeow International stock appears to be overvalued.
The current stock price of HK$2.44 is trading 11.9% above its estimated GF Value™ of HK$2.18.
GuruFocus considers Pak Fah Yeow International to be Modestly Overvalued.
Key valuation signals for HKSE:00239:
PS Ratio: 3.55 (near median its 10-year median of 3.89)
GF Value™: HK$2.18 vs. price of HK$2.44 (11.9% above fair value)
Industry Position: 52.4% above the Drug Manufacturers median (#604 of 950)
No single metric tells the full story. See the HKSE:00239 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment.The Groups businesses cover Hong Kong, Macau, other regions in the Peoples Republic of China (the PRC or Chinese Mainland), Southeast Asia, North America and the United Kingdom.
76GF Score
Get the complete analysis for HKSE:00239
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00239 has been successfully added to your 
